Study Stopped
PI has left the university
Hidradenitis - an Analysis of Genetic Traits and Linkages in Families
Hidradenitis Suppurativa - a Mendelian Trait? Genetic Pedigree and Linkage Analysis
1 other identifier
observational
97
1 country
1
Brief Summary
The aim of this study is to find a genetic link or family trait connecting persons with Hidradenitis Suppurativa (HS) to each other. As a result, discover the cause and perhaps treatment for Hidradenitis Suppurativa (HS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 17, 2019
CompletedFirst Submitted
Initial submission to the registry
January 25, 2023
CompletedFirst Posted
Study publicly available on registry
February 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2026
CompletedMarch 4, 2026
March 1, 2026
6.5 years
January 25, 2023
March 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hidradenitis Suppurativa Genetic linkage
Determine the genetic linkage of Hidradenitis Suppurativa (HS). Measurements are based on Gene panel assays of DNA specimen (blood or saliva) to find rare variant(s) linked to HS. Specimen samples include those provided by affected participants, and when possible they're biological family. A Gene panel diagnostic determines the number of variants (or mutation) in multiple genes, potentially identifying a genetic linkage of mendelian inheritance.
1-Day Study Participation
Secondary Outcomes (3)
Demographics of Participant Population
1-Day Study Participation
Pattern of Affected Family
1-Day Study Participation
Number of Variants Shared
1-Day Study Participation
Study Arms (2)
Affected
(Affected) persons with a medical history of symptoms related to Hidradenitis Suppurativa.
Unaffected-control
(Unaffected) family of participants, having no history of symptoms related to Hidradenitis Suppurativa.
Eligibility Criteria
Participants with a history of Hidradenitis Suppurativa, and their biological family members.
You may qualify if:
- Participants (affected) with Hidradenitis Suppurativa and related symptoms
- Family (unaffected) of participants with Hidradenitis Suppurativa
You may not qualify if:
- Children under 7-years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Chicago Medicine
Chicago, Illinois, 60637, United States
Biospecimen
Blood (adults, approx. 8-9 mL), (pediatric, 2-4 mL); or Saliva (1.5 - 2.0 mL) specimen for DNA (Gene panel) analysis.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Nagele, MD, MSc
University of Chicago Medicine
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2023
First Posted
February 2, 2023
Study Start
September 17, 2019
Primary Completion
February 27, 2026
Study Completion
February 27, 2026
Last Updated
March 4, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share